Article

(2024) Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2204-2256. ISSN 01406736 (ISSN)

(2024) Clinical heterogeneity in families with multiple cases of inborn errors of immunity. Clinical immunology (Orlando, Fla.). p. 109896. ISSN 1521-7035 (Electronic) 1521-6616 (Linking)

(2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2162-2203. ISSN 01406736 (ISSN)

(2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2100-2132. ISSN 01406736 (ISSN)

(2024) Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2057-2099. ISSN 01406736 (ISSN)

(2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2133-2161. ISSN 01406736 (ISSN)

(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 203-234. ISSN 0140-6736

(2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. Eclinicalmedicine. p. 23.

(2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematology. e713-e734. ISSN 2352-3026

(2023) The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet. pp. 313-335. ISSN 0140-6736

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients. Immunological Investigations. pp. 381-394. ISSN 0882-0139

(2022) Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019. Archives of Iranian Medicine. pp. 767-778. ISSN 10292977 (ISSN)

(2022) Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature. Immunological Investigations. pp. 331-342. ISSN 0882-0139

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736

(2021) Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. Pediatric Allergy and Immunology. pp. 1335-1348.

(2021) Disseminated Intravascular Coagulation Associated with Large Deletion of Immunoglobulin Heavy Chain. Iranian journal of allergy, asthma, and immunology. pp. 778-783.

(2020) Monogenic Primary Immunodeficiency Disorder Associated with Common Variable Immunodeficiency and Autoimmunity. International Archives of Allergy and Immunology. pp. 706-714. ISSN 1018-2438

(2019) Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort. Journal of Allergy and Clinical Immunology-in Practice. 864-+. ISSN 2213-2198